Logo image of LRN

STRIDE INC (LRN) Stock Fundamental Analysis

NYSE:LRN - New York Stock Exchange, Inc. - US86333M1080 - Common Stock - Currency: USD

135.86  +0.4 (+0.3%)

After market: 138 +2.14 (+1.58%)

Fundamental Rating

7

Taking everything into account, LRN scores 7 out of 10 in our fundamental rating. LRN was compared to 72 industry peers in the Diversified Consumer Services industry. LRN has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. LRN is growing strongly while it is still valued neutral. This is a good combination! These ratings would make LRN suitable for growth and quality investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year LRN was profitable.
In the past year LRN had a positive cash flow from operations.
In the past 5 years LRN has always been profitable.
In the past 5 years LRN always reported a positive cash flow from operatings.
LRN Yearly Net Income VS EBIT VS OCF VS FCFLRN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

The Return On Assets of LRN (13.03%) is better than 91.55% of its industry peers.
Looking at the Return On Equity, with a value of 20.46%, LRN belongs to the top of the industry, outperforming 87.32% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 13.60%, LRN belongs to the top of the industry, outperforming 90.14% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for LRN is below the industry average of 11.60%.
The 3 year average ROIC (9.47%) for LRN is below the current ROIC(13.60%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 13.03%
ROE 20.46%
ROIC 13.6%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
LRN Yearly ROA, ROE, ROICLRN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

LRN has a better Profit Margin (12.30%) than 83.10% of its industry peers.
LRN's Profit Margin has improved in the last couple of years.
LRN has a better Operating Margin (15.25%) than 80.28% of its industry peers.
LRN's Operating Margin has improved in the last couple of years.
With a Gross Margin value of 38.54%, LRN perfoms like the industry average, outperforming 42.25% of the companies in the same industry.
LRN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.25%
PM (TTM) 12.3%
GM 38.54%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
LRN Yearly Profit, Operating, Gross MarginsLRN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

8

2. Health

2.1 Basic Checks

LRN has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for LRN has been increased compared to 1 year ago.
LRN has more shares outstanding than it did 5 years ago.
LRN has a better debt/assets ratio than last year.
LRN Yearly Shares OutstandingLRN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
LRN Yearly Total Debt VS Total AssetsLRN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 7.45 indicates that LRN is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.45, LRN belongs to the top of the industry, outperforming 92.96% of the companies in the same industry.
LRN has a debt to FCF ratio of 1.96. This is a very positive value and a sign of high solvency as it would only need 1.96 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.96, LRN is in the better half of the industry, outperforming 78.87% of the companies in the same industry.
A Debt/Equity ratio of 0.35 indicates that LRN is not too dependend on debt financing.
LRN's Debt to Equity ratio of 0.35 is in line compared to the rest of the industry. LRN outperforms 49.30% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.96
Altman-Z 7.45
ROIC/WACC1.53
WACC8.87%
LRN Yearly LT Debt VS Equity VS FCFLRN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

LRN has a Current Ratio of 6.02. This indicates that LRN is financially healthy and has no problem in meeting its short term obligations.
LRN has a better Current ratio (6.02) than 92.96% of its industry peers.
A Quick Ratio of 5.93 indicates that LRN has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.93, LRN belongs to the best of the industry, outperforming 92.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.02
Quick Ratio 5.93
LRN Yearly Current Assets VS Current LiabilitesLRN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 51.26% over the past year.
The Earnings Per Share has been growing by 39.31% on average over the past years. This is a very strong growth
LRN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.13%.
Measured over the past years, LRN shows a quite strong growth in Revenue. The Revenue has been growing by 14.97% on average per year.
EPS 1Y (TTM)51.26%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%31.82%
Revenue 1Y (TTM)13.13%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%16.31%

3.2 Future

Based on estimates for the next years, LRN will show a very strong growth in Earnings Per Share. The EPS will grow by 20.90% on average per year.
Based on estimates for the next years, LRN will show a quite strong growth in Revenue. The Revenue will grow by 9.53% on average per year.
EPS Next Y42.69%
EPS Next 2Y25.31%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue Next Year15.1%
Revenue Next 2Y10.95%
Revenue Next 3Y10.18%
Revenue Next 5Y9.53%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
LRN Yearly Revenue VS EstimatesLRN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B
LRN Yearly EPS VS EstimatesLRN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 22.68 indicates a rather expensive valuation of LRN.
Based on the Price/Earnings ratio, LRN is valued a bit cheaper than the industry average as 61.97% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.29. LRN is around the same levels.
A Price/Forward Earnings ratio of 18.53 indicates a rather expensive valuation of LRN.
LRN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. LRN is cheaper than 67.61% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of LRN to the average of the S&P500 Index (21.08), we can say LRN is valued inline with the index average.
Industry RankSector Rank
PE 22.68
Fwd PE 18.53
LRN Price Earnings VS Forward Price EarningsLRN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

LRN's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. LRN is cheaper than 63.38% of the companies in the same industry.
66.20% of the companies in the same industry are more expensive than LRN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.78
EV/EBITDA 12.37
LRN Per share dataLRN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of LRN may justify a higher PE ratio.
A more expensive valuation may be justified as LRN's earnings are expected to grow with 20.90% in the coming years.
PEG (NY)0.53
PEG (5Y)0.58
EPS Next 2Y25.31%
EPS Next 3Y20.9%

0

5. Dividend

5.1 Amount

LRN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

STRIDE INC

NYSE:LRN (4/17/2025, 8:04:00 PM)

After market: 138 +2.14 (+1.58%)

135.86

+0.4 (+0.3%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)01-28 2025-01-28/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners114.95%
Inst Owner Change0.02%
Ins Owners2.78%
Ins Owner Change-1.31%
Market Cap5.92B
Analysts82.22
Price Target136.68 (0.6%)
Short Float %10.02%
Short Ratio4.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)167.41%
Min EPS beat(2)3.28%
Max EPS beat(2)331.54%
EPS beat(4)4
Avg EPS beat(4)89.1%
Min EPS beat(4)3.28%
Max EPS beat(4)331.54%
EPS beat(8)8
Avg EPS beat(8)67.46%
EPS beat(12)11
Avg EPS beat(12)23.16%
EPS beat(16)14
Avg EPS beat(16)24.03%
Revenue beat(2)2
Avg Revenue beat(2)5.17%
Min Revenue beat(2)2.13%
Max Revenue beat(2)8.2%
Revenue beat(4)4
Avg Revenue beat(4)3.15%
Min Revenue beat(4)0.58%
Max Revenue beat(4)8.2%
Revenue beat(8)7
Avg Revenue beat(8)2.96%
Revenue beat(12)11
Avg Revenue beat(12)2.91%
Revenue beat(16)15
Avg Revenue beat(16)3.18%
PT rev (1m)1.9%
PT rev (3m)36.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.1%
EPS NY rev (1m)-0.69%
EPS NY rev (3m)1.22%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.34%
Valuation
Industry RankSector Rank
PE 22.68
Fwd PE 18.53
P/S 2.7
P/FCF 22.78
P/OCF 18.37
P/B 4.49
P/tB 6.68
EV/EBITDA 12.37
EPS(TTM)5.99
EY4.41%
EPS(NY)7.33
Fwd EY5.4%
FCF(TTM)5.97
FCFY4.39%
OCF(TTM)7.4
OCFY5.44%
SpS50.36
BVpS30.27
TBVpS20.33
PEG (NY)0.53
PEG (5Y)0.58
Profitability
Industry RankSector Rank
ROA 13.03%
ROE 20.46%
ROCE 18.17%
ROIC 13.6%
ROICexc 22.29%
ROICexgc 36.28%
OM 15.25%
PM (TTM) 12.3%
GM 38.54%
FCFM 11.84%
ROA(3y)8.12%
ROA(5y)6.23%
ROE(3y)14.65%
ROE(5y)11.29%
ROIC(3y)9.47%
ROIC(5y)7.52%
ROICexc(3y)14.4%
ROICexc(5y)11.23%
ROICexgc(3y)26.36%
ROICexgc(5y)21.09%
ROCE(3y)12.66%
ROCE(5y)10.14%
ROICexcg growth 3Y21.6%
ROICexcg growth 5Y11.49%
ROICexc growth 3Y26.37%
ROICexc growth 5Y16.18%
OM growth 3Y19.4%
OM growth 5Y22.26%
PM growth 3Y29.12%
PM growth 5Y22.27%
GM growth 3Y2.45%
GM growth 5Y1.54%
F-Score7
Asset Turnover1.06
Health
Industry RankSector Rank
Debt/Equity 0.35
Debt/FCF 1.96
Debt/EBITDA 1.05
Cap/Depr 56.31%
Cap/Sales 2.84%
Interest Coverage 41.42
Cash Conversion 72.36%
Profit Quality 96.31%
Current Ratio 6.02
Quick Ratio 5.93
Altman-Z 7.45
F-Score7
WACC8.87%
ROIC/WACC1.53
Cap/Depr(3y)62.27%
Cap/Depr(5y)61.45%
Cap/Sales(3y)3.58%
Cap/Sales(5y)3.69%
Profit Quality(3y)114.31%
Profit Quality(5y)120.41%
High Growth Momentum
Growth
EPS 1Y (TTM)51.26%
EPS 3Y39.51%
EPS 5Y39.31%
EPS Q2Q%31.82%
EPS Next Y42.69%
EPS Next 2Y25.31%
EPS Next 3Y20.9%
EPS Next 5YN/A
Revenue 1Y (TTM)13.13%
Revenue growth 3Y9.9%
Revenue growth 5Y14.97%
Sales Q2Q%16.31%
Revenue Next Year15.1%
Revenue Next 2Y10.95%
Revenue Next 3Y10.18%
Revenue Next 5Y9.53%
EBIT growth 1Y56.46%
EBIT growth 3Y31.23%
EBIT growth 5Y40.56%
EBIT Next Year96.56%
EBIT Next 3Y33.21%
EBIT Next 5Y23.21%
FCF growth 1Y56.07%
FCF growth 3Y38.43%
FCF growth 5Y18.44%
OCF growth 1Y34.37%
OCF growth 3Y27.61%
OCF growth 5Y14.51%